title: [Molecular mechanisms of ischemic-reperfusion syndrome and its personalized therapy].
abstract: Cardiovascular pathologies are the major causes of morbidity and mortality in the world. Cessation of the blood flow in large vessels, supplying tissues with oxygen and substrates, leads to ischemic conditions accompanied by unwanted shifts of oxidative metabolism and rise of the reactive oxygen species (ROS) generation. Small amounts of ROS are essential elements of the cell metabolism, however pathological elevation of ROS jeopardizes the survival of cells, organs and even organisms. Paradoxically, blood flow restoration during prolonged ischemia leads to oxidative stress that is often fatal for a live system. Oxygen paradox appears to be a limiting factor in clinical practice that intuitively seeks for immediate and complete restoration of a damaged blood flow. Mitochondrion is a major ROS source and a key element of pro-apoptotic signaling, however it is clear, that mitochondria are the main target for anti-ischemic treatment. In the present review we consider two ways of such anti-ischemic strategy, bringing ischemic tolerance to the organ through mitochondrial involvement, such as intrinsic, biological, or artificial, pharmacological adaptive systems (preconditioning). The latter is aimed to simulate elements and high efficiency of intrinsic protective system. The role of antioxidants in anti-ischemic therapy and their effects on preconditioning signaling are discussed in the review.
authors.forename: O A
authors.initials: OA
authors.lastname: Grebenchikov
authors.forename: V V
authors.initials: VV
authors.lastname: Likhvantsev
authors.forename: E Iu
authors.initials: EIu
authors.lastname: Plotnikov
authors.forename: D N
authors.initials: DN
authors.lastname: Silachev
authors.forename: I B
authors.initials: IB
authors.lastname: Pevzner
authors.forename: L D
authors.initials: LD
authors.lastname: Zorova
authors.forename: D B
authors.initials: DB
authors.lastname: Zorov
mesh_terms: D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D019194:Ischemic Preconditioning; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism*; D018384:Oxidative Stress / Q000187:drug effects; D057285:Precision Medicine; D017382:Reactive Oxygen Species / Q000378:metabolism*; D015427:Reperfusion Injury / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D013577:Syndrome
chemical_list: D000975:Antioxidants; D017382:Reactive Oxygen Species